Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-002578
Accepted
2024-08-20 00:15:09
Documents
1
Effectiveness Date
2024-08-19
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 595
  Complete submission text file 9999999995-24-002578.txt   1793
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-281433 | Film No.: 241222517
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)